Contact us
Expertise in real world data
Late phase CRO: Oxon Epidemiology
Expertise in
Real World
Data
Full service global scientific service provider
specialising in field and database observational studies
Late phase CRO: Oxon Epidemiology
2019/20
Free Keynote Webinar Series
Understanding Healthcare for Field and Secondary Data Observational Studies in EU and Asian Countries
Welcome to OXON Epidemiology
OXON'S 2019/20 FREE KEYNOTE LIVE WEBINAR SERIES:
Understanding Health Care for Observational Studies in The Nordics
5 June 2019 at 5 pm - REGISTER HERE
OXON wins prize for PRAC-approved novel PASS design at ICPE 2018
REQUEST A DISCUSSION FOR YOUR NEXT PASS STUDY
Get OXON´s Quantitative Review of PASS Risk Minimisation Studies recently presented at EMA and EFPIA PV Expert Group.
ASK US FOR A PRESENTATION WITH FURTHER ANALYSES, CASE STUDIES AND INSIGHTS, focussed on your NEEDS
OXON Epidemiology is a full service scientific and operational provider for multi-country Field, Database and Hybrid observational studies for Safety, HEOR/market access, Drug development and Marketing:
  • Prospective and registry studies
  • Cross-sectional studies
  • Retrospective chart review studies
  • Risk minimisation surveys
  • Database studies
  • Hybrid studies
OXON has been selected as a preferred provider by several big pharma companies.
With offices in London and Madrid, OXON applies world-class epidemiological & operational experience, and innovative technologies, to help clients obtain high quality real-world data to improve patient and public health.
GLOBAL REACH:
Our long-term alliance with a top tier CRO provides global geographical local country operational support and links with leading pharmacoepidemiologists in EU and Asia for database studies.
LINKS WITH REGULATORS:
Joint Coordinator of the EMA ENCePP Special Interest Group on Impact of PV Activities
WORLD CLASS SCIENCE:
  • Academic link with the London School of Hygiene & Tropical Medicine
  • Leading academic methodological and clinical consultants: e.g. Professor Stuart Pocock (30+ NEJM, 40+ Lancets; 2013 Bradford Hill Medal; extensive EMA and FDA experience)
  • Publications by OXON staff include Lancet (x7), JAMA (x1), BMJ (x4), among many others
For People involved in observational studies:
Epidemiologists, Drug Safety specialists, Scientific Leads, Medical Affairs and others



Click to read more
OXON initiatives and activities at the European Medicines Agency






Click to read more
Access to OXON’s open and closed projects by study investigators, collaborating physicians and patients & relatives



Click to read more
Network of alliances and academic & clinical consultants






Click to read more
Courses and Resources
Courses
and Resources
Late phase CRO: Oxon Epidemiology
OXON
Activities
Access for Investigators and Patients
Access for Investigators
and Patients
WorldWide Network
WorldWide
Network
Copyright © 2013 Oxon All Rights Reserved - Late phase CRO
logo oxon
Copyright © 2013.
All Rights Reserved - Late Phase CRO
Quality Policy
Site Menu
What we do
Prospective observational studies and registries, retrospective chart review cohort and cross-sectional studies, cross-sectional surveys, database studies, hybrid field and database studies, risk minimisation , Risk management plans, pragmatic trials, data aggregation and integration, Meta-analysis, H-E / Q.O.L. within observational studies, Consulting, , Validated eDC and e-Technologies,.
Contact
OXON EPIDEMIOLOGY, Ltd.
16 Upper Woburn Place
London WC1H 0AF, UK
Phone: +44(0) 203 741 8054
E-mail:
Legal terms and conditions
Privacy policy